Literature DB >> 18661327

The role of biglycan in the heart.

Erika Bereczki1, Miklós Sántha.   

Abstract

Biglycan, a member of the small leucine rich proteoglycan family, is known to be expressed in almost every tissue of our body. Although there are increasing amount of data on the biological role of biglycan, its cardiac function is still not totally clarified. Cardiac protein profiling of biglycan transgenic mice and other studies revealed its involvement in heart failure, myocardial remodeling, and a possible role in promoting cardioprotection. The localization of biglycan on the cell surface and its "pericellular" arrangement as well as the presence of reactive GAG chains on its surface suggest an involvement in transmission of extracellular signals to intracellular signaling molecules and a role in regulation of Ca(++) trafficking. In this review, the role of biglycan in the heart under normal physiological as well as pathological conditions is summarized and critically discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18661327     DOI: 10.1080/03008200802148504

Source DB:  PubMed          Journal:  Connect Tissue Res        ISSN: 0300-8207            Impact factor:   3.417


  5 in total

1.  The proteoglycan biglycan enhances antigen-specific T cell activation potentially via MyD88 and TRIF pathways and triggers autoimmune perimyocarditis.

Authors:  Zoran V Popovic; Shijun Wang; Maria Papatriantafyllou; Ziya Kaya; Stefan Porubsky; Maria Meisner; Mahnaz Bonrouhi; Sven Burgdorf; Marian F Young; Liliana Schaefer; Hermann-Josef Gröne
Journal:  J Immunol       Date:  2011-11-16       Impact factor: 5.422

Review 2.  Cardiac extracellular matrix remodeling: fibrillar collagens and Secreted Protein Acidic and Rich in Cysteine (SPARC).

Authors:  Sarah McCurdy; Catalin F Baicu; Stephane Heymans; Amy D Bradshaw
Journal:  J Mol Cell Cardiol       Date:  2009-07-03       Impact factor: 5.000

Review 3.  Contribution of extracellular matrix to the mechanical properties of the heart.

Authors:  Gregory M Fomovsky; Stavros Thomopoulos; Jeffrey W Holmes
Journal:  J Mol Cell Cardiol       Date:  2009-08-15       Impact factor: 5.000

4.  Functional and structural studies of tolloid-like 1 mutants associated with atrial-septal defect 6.

Authors:  Lukasz Sieron; Marta Lesiak; Izabela Schisler; Zofia Drzazga; Andrzej Fertala; Aleksander L Sieron
Journal:  Biosci Rep       Date:  2019-01-08       Impact factor: 3.840

5.  Biglycan fragmentation in pathologies associated with extracellular matrix remodeling by matrix metalloproteinases.

Authors:  Federica Genovese; Natasha Barascuk; Lise Larsen; Martin Røssel Larsen; Arkadiusz Nawrocki; Yili Li; Qinlong Zheng; Jianxia Wang; Sanne Skovgård Veidal; Diana Julie Leeming; Morten Asser Karsdal
Journal:  Fibrogenesis Tissue Repair       Date:  2013-05-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.